Study of XL999 in Patients With Multiple Myeloma
NCT00304590
·
clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
4
Enrollment
INDUSTRY
Sponsor class
Stopped
Study was terminated due to cardiac toxicities in the subjects
Conditions
Multiple Myeloma
Interventions
DRUG:
XL999
Sponsor
Symphony Evolution, Inc.